CardioMEMS PA Sensor and Delivery System (CM2000); CardioMEMS HF System
ABBOTT MEDICAL · Decision date Sep 11, 2026
What did the FDA decide?
This 30-Day Notice for supplement S092 to PMA P100045 records a process change for the CardioMEMS PA Sensor and Delivery System (CM2000) and CardioMEMS HF System. The stated change concerns routine bacterial endotoxin and bioburden testing, classified as a manufacturer, sterilizer, packager, or supplier process change.
The decision field shows OK30, and the supplement type is a 30-Day Notice rather than an original PMA approval. The record does not state which testing steps, specifications, or manufacturing sites were altered, nor does it provide evidence of safety or clinical effectiveness. No new indication or clinical benefit is described in the available fields.
FDA approval order statement
changes for routine bacterial endotoxin and bioburden testing
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100045/S092
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- MOM
- Decision code
- OK30
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, hemodynamic, implantable.
- Applicant
- Abbott Medical
- Product code
- MOM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P100045. Subsequent supplements may change the device or its indications.
FDA decision timeline
P100045 · Original PMA
CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM
P100045/S092 received
Application receipt date recorded by FDA.
P100045/S092 · FDA decision
30-Day Notice
P100045/S091 · Related supplement
CardioMEMS HF System; Merlin.net PCN HF Portal (Model MN6000); CardioMEMS Backend Web Application (Model CM4000); HF Clo
P100045/S093 · Related supplement
CardioMEMS PA Sensor and Delivery System
Timeline entries are records held by MedtechLedger for P100045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | May 28, 2014 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA | |
CardioMEMS PA Sensor and Delivery SystemP100045/S093 | ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA |
Explore the linked device profile
Other records with product code MOM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cordella Pulmonary Artery Sensor SystemP230040/S030 | Endotronix, Inc. | PMA supplement | Oct 29, 2026 | FDA |
| Endotronix, Inc. | PMA supplement | Oct 20, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 387 Nerem St. NW, Suite #500, Atlanta, GA, 30313
Sources and methodology
- Original FDA record: P100045/S092
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




